Benavent E, Lora-Tamayo J, Ulldemolins M, Pons-Oltra P, et al. Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of
dalbavancin for short-term therapy in patients with chronic prosthetic joint
infections. Antimicrob Agents Chemother 2025;69:e0077325.
PMID: 41105523
|